Structure-activity relationship within a series of m-diaminobenzene derivatives. 1980

M M Shahin, and A Bugaut, and G Kalopissis

We investigated the mutagenicity of m-diaminobenzene (m-phenylenediamine) and four 2,4-diaminoalkylbenzenes (methyl, ethyl, isopropyl and n-butyl) in Salmonella typhimurium strains TA100, TA1538 and TA98 in the absence and presence of S9 induced by Acoclor 1254. m-Diaminobenzene was the most active mutagen, followed by 2,4-diaminotoluene and 2,4-diaminoethylbenzene, resp. Negative response was observed for both 2,4-diaminoisopropylbenzene and 2,4-diamino-n-butylbenzene. Thus, depending on the size of the substituting alkyl group at the C1 position of 2,4-diaminoalkylbenzene, a decline and loss of mutagenic activity was observed.

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D010655 Phenylenediamines Aniline compounds that contain two amino groups. They are used as a precursor in the synthesis of HETEROCYCLIC COMPOUNDS and POLYMERS. p-Phenylenediamine is used in the manufacture of HAIR DYES and is an ALLERGEN.
D003959 Diamines Organic chemicals which have two amino groups in an aliphatic chain. Diamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005821 Genetic Techniques Chromosomal, biochemical, intracellular, and other methods used in the study of genetics. Genetic Technic,Genetic Technics,Genetic Technique,Technic, Genetic,Technics, Genetic,Technique, Genetic,Techniques, Genetic
D001555 Benzene Derivatives Organic compounds derived from BENZENE. Derivatives, Benzene
D012486 Salmonella typhimurium A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. Salmonella typhimurium LT2
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

M M Shahin, and A Bugaut, and G Kalopissis
October 1990, Carcinogenesis,
M M Shahin, and A Bugaut, and G Kalopissis
May 1994, Mutation research,
M M Shahin, and A Bugaut, and G Kalopissis
January 1996, Bioscience, biotechnology, and biochemistry,
M M Shahin, and A Bugaut, and G Kalopissis
July 1971, Arzneimittel-Forschung,
M M Shahin, and A Bugaut, and G Kalopissis
February 2019, Chemistry & biodiversity,
M M Shahin, and A Bugaut, and G Kalopissis
December 2021, Journal of enzyme inhibition and medicinal chemistry,
M M Shahin, and A Bugaut, and G Kalopissis
September 1988, European journal of cancer & clinical oncology,
M M Shahin, and A Bugaut, and G Kalopissis
January 1996, Polish journal of pharmacology,
M M Shahin, and A Bugaut, and G Kalopissis
May 2000, Bioorganic & medicinal chemistry,
M M Shahin, and A Bugaut, and G Kalopissis
June 2017, Anticancer research,
Copied contents to your clipboard!